Transcription factor-driven metabolic stratification reveals glycolytic and lipogenic subtypes with distinct prognostic and functional features in pancreatic cancer
Oct 2026· Frontiers in Oncology· Vol 16· 0 citations· 48 references
Medicine
TL;DR
TF-based classification delineates glycolytic and lipogenic subtypes in PDAC, underscoring the critical role of TF-regulated metabolic programs in patient stratification and support the development of metabolism-targeted therapeutic strategies.
Abstract
Objective Pancreatic ductal adenocarcinoma (PDAC) exhibits profound molecular and metabolic heterogeneity associated with distinct phenotypic states. However, the contribution of transcription factor (TF)-driven regulatory programs to metabolic subtype stratification remains poorly understood. This study aims to determine whether TF-based classification can identify prognostically relevant glycolytic and lipogenic PDAC subtypes. Methods Bulk transcriptomic data from multiple PDAC cohorts and single-cell RNA sequencing data were integrated to characterize TF-associated metabolic heterogeneity. Metabolic signatures and TFs were quantified using single-sample gene set enrichment analysis (ssGSEA) and AddModule Score (AMS). Differential expression, enrichment analysis, integrative bulk and single-cell transcriptomic analysis, and deep neural network-based metabolic flux modeling were performed to investigate metabolic programs and functional differences between TF-defined subtypes. Additionally, RNA interference, RT-qPCR, lipid droplets staining, lactate assay, and transwell assays were used to evaluate the roles of TP63 in metabolic regulation. Results Glycolytic and lipogenic TF-defined metabolic subtypes were identified across multiple independent PDAC cohorts. These subtypes exhibited distinct metabolic programs, differentiation states, and prognostic outcomes. The glycolytic TF-defined subtype was associated with worse prognosis and differentiation, whereas the lipogenic TF-defined subtype exhibited more favorable clinical features. Integration of public bulk and single-cell transcriptomic analyses, together with deep neural network-based metabolic flux modeling, revealed consistent metabolic heterogeneity at both cellular and functional levels. Notably, TP63 was identified as a potential regulator of glycolytic-lipogenic metabolic reprogramming in PDAC. Conclusions TF-based classification delineates glycolytic and lipogenic subtypes in PDAC, underscoring the critical role of TF-regulated metabolic programs in patient stratification. These findings highlight the prognostic significance of glycolytic and lipogenic metabolic heterogeneity and support the development of metabolism-targeted therapeutic strategies.
BACKGROUND
Pancreatic Adenocarcinoma (PAAD) is characterized by pronounced molecular heterogeneity and profound metabolic reprogramming. Glutamine metabolism plays a critical role in sustaining tumor growth and shaping the tumor microenvironment; however, its contribution to molecular heterogeneity, immune characterist...
Wen-Yu Li, Min Luo, Xue-Hong Wang et al.· Current Medicinal Chemistry· 0 citations
Lipid metabolic reprogramming is a hallmark of tumor progression, yet the role of low-density lipoprotein (LDL) metabolism in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study aimed to systematically characterize LDL metabolism and identify clinically relevant regulators.
Integrated...
Background Macrophage-dependent immune remodeling and altered lipid metabolism are closely related to liver cancer behavior. In hepatocellular carcinoma (HCC), the survival relevance of macrophage-associated lipid metabolism genes (MLMGs) remains insufficiently characterized. This work evaluated MLMG-related molecular...
Yu Yang, Man-Man Lu, Huapeng Zhang et al.· Frontiers in Immunology· 0 citations
These findings provide a comprehensive characterization of glycolytic dysregulation in PCOS and identify GPT2 as a potential metabolic regulator linking altered energy metabolism to ovarian dysfunction, and provide a molecular framework for future studies investigating metabolism‐ and nutrition‐based intervention strat...
Hepatocellular carcinoma (HCC) is characterized by extensive metabolic reprogramming, and immune evasion is closely linked to dysregulated lactate metabolism. However, the tumor-intrinsic mechanisms that translate extracellular lactate signals into Treg-associated immune remodeling remain poorly understood. Here,...
XCL1 is associated with glycolysis-related metabolic alterations and OSCC cell growth in vitro, which support further investigation of XCL1 in OSCC, while in vivo studies and larger clinical cohorts are needed to further evaluate its biological and therapeutic relevance.
Li-Ru Zhang, Wei Liu, Di Wang et al.· Journal of Stomatology Oral...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.